Partner Headlines - BMY

  1. Could Merck's 'Meaningful' Keytruda Royalty Give Bristol-Myers ...

    Investors Business Daily
  2. AskSlim Market Week - Friday, January 20

    TalkMarkets
  3. Dow Industrials Take Lead As Trump Sworn In; Nvidia Sits Out ...

    Investors Business Daily
  4. Stocks Fall Off Highs; Trump Sworn In As President

    Investors Business Daily
  5. Bristol-Myers Slides After Another Lung Cancer Drug Setback ...

    TalkMarkets
  6. Stocks Up Nicely In Early Trade; Apple Shrugs Off China Trade ...

    Investors Business Daily
  7. Stock Futures Steer Higher; Merck, Skyworks, Emerge Energy Climb

    Investors Business Daily
  8. Bristol-Myers Won't Seek Accelerated Opdivo Lung Cancer OK

    Investors Business Daily
  9. FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink

    Investors Business Daily
  10. Analysts See Merck Rally Continuing After Lung Cancer Drug News ...

    TalkMarkets
  11. Eli Lilly Rebounds On Chemo-Drug Patent Win Vs. Generic Teva

    Investors Business Daily
  12. Bristol-Myers Threatens Merck's 'Head Start' In Lung Cancer: ...

    Investors Business Daily
  13. Stocks Wipe Away Losses, Close Higher; Drug Stocks Feel Trump ...

    Investors Business Daily
  14. Merck Lung-Cancer Drug May Get OK For Large Patient Population

    Investors Business Daily
  15. Bristol-Myers slips after FDA gives Merck lung cancer therapy ...

    TalkMarkets
  16. Calithera Pharma In Focus, Part 3 - Arginase Inhibitor And Acquisition ...

    TalkMarkets
  17. Biotech Blahs: Out Of Favor But Great For Stock Pickers

    TalkMarkets
  18. Cempra Plunges To 52-Week Low, Shire Drug Label Expanded

    TalkMarkets
  19. Stocks Going Ex Dividend the First Week of January

    TalkMarkets
  20. J&J Back In Talks With Actelion, Teva Settles Corruption Probe

    TalkMarkets
  21. Gilead Is A Hail Mary: 3 Better Stocks To Consider

    TalkMarkets
  22. Biotechs Fade Again In Late Day Sell-Off

    TalkMarkets
  23. Bristol-Myers Will Gain In Lung Cancer Square-Off Vs. Merck: ...

    Investors Business Daily
  24. Jefferies Says Sell Merck, Buy Bristol-Myers Heading Into New ...

    TalkMarkets
  25. Incyte Could Step Onto Auction Block With Strong Jakafi Sales: ...

    Investors Business Daily
  26. Morning Call For Monday, Dec. 19

    TalkMarkets
  27. The FDA: Small-Cap Catalyst Or Small-Cap Killer?

    TalkMarkets
  28. Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks With ALIOF

    TalkMarkets
  29. Calithera In Focus, Part 2 - Upcoming Catalysts In TNBC And RCC

    TalkMarkets
  30. Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal

    TalkMarkets
  31. Calithera Pharma In Focus Part 1 - Checkpoint Inhibition

    TalkMarkets
  32. AskSlim Market Week - 11/11/16

    TalkMarkets
  33. Rayno Biobeat #3…Trump Biotech Rally Leads Market Up

    TalkMarkets
  34. Trump Triumphs

    TalkMarkets
  35. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets
  36. Rayno Biobeat #2…Good Value in Large Cap Biopharmaceuticals

    TalkMarkets
  37. Fundamentals Remain Strong In The Pharma Sector

    TalkMarkets
  38. Biotech Meltdown: Financial Metrics Offer Few Clues For What ...

    TalkMarkets
  39. Surviving Hillary - Surviving Donald: The Election Portfolio

    TalkMarkets
  40. Daily Update: Core Durable Goods Down 21 Straight Months

    TalkMarkets
  41. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets
  42. 5 Stocks To Watch Before The Market Opens Tomorrow (October 27, ...

    TalkMarkets
  43. Big Pharma’s Big Biotech Problem

    Dividend.com
  44. Bristol-Myers Falls As Merck Upstages With New Lung Cancer Data

    TalkMarkets
  45. Earnings ESP

    TalkMarkets
  46. Rayno 2016 Life Science Portfolio Update

    TalkMarkets
  47. The Gap Inc. Leads 85 Stocks Going Ex-Dividend Next Week

    Dividend.com
  48. Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to ...

    TalkMarkets
  49. Trending on Dividend.com: Bristol-Myers Disappoints and DHT Surprises, ...

    Dividend.com
  50. 3 Big Drugmakers That Beat Wall Street Q2 Estimates Thursday

    Investors Business Daily
  51. Amazon, Alphabet, Baidu, Ford, Celgene On Tap Thursday

    Investors Business Daily
  52. Investing Action Plan: Amazon, Alphabet, Baidu, Ford, Celgene

    Investors Business Daily
  53. Investing Action Plan: Apple, Facebook, Amazon, Big Oil, Boeing, ...

    Investors Business Daily
  54. 5 Big Drugmakers Reporting Earnings Next Week

    Investors Business Daily
  55. Ken Fisher's Best Investments: Credicorp, Ambev, Tata Motors

    GuruFocus
  56. Bristol-Myers Looks To A Promising Future

    Benzinga
  57. Barron's Picks And Pans: Bristol-Myers Squibb, KeyCorp, Core-Mark ...

    Benzinga
  58. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD
  59. Earnings Recap For January 28

    Benzinga
  60. Bristol Myers Ticks Higher Following Q4 Beat, Encouraging Guidance

    Benzinga
  61. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus
  62. JNJ Kicks Off Health Care Earnings—What About Deals, Buybacks?

    Benzinga
  63. Stock Marquee Crowded With Oil, Apple, and the Fed

    Benzinga
  64. Benzinga's Top Downgrades

    Benzinga
  65. Bristol-Myers Squibb's Opdivo + Yervoy Receives Expanded FDA ...

    Benzinga
  66. Benzinga's Top Upgrades

    Benzinga
  67. Fast Money Traders Share Their Biotech Picks

    Benzinga
  68. Dual Therapeutics Announces Oncology Strategic Collaboration ...

    GuruFocus
  69. Mylan, Momenta Team Up To Develop Biosimilar Drugs

    IBD
  70. 3 Potential Blockbuster Drugs Launching in 2016

    IBD
  71. Lilly Guidance Misses Estimates On Lower Sales

    IBD
  72. Baxalta Cuts Cancer Deal As Shire Circles Nearer

    IBD
  73. 5 Top Stocks of the Outperforming Vanguard Health Care Fund

    GuruFocus
  74. Glaxo's ViiV Acquiring Bristol-Myers' HIV Candidates

    IBD
  75. Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare ...

    Benzinga
  76. Strategic Beta ETFs Among Year's Top Performers

    IBD
  77. Fast Money Picks For December 15

    Benzinga
  78. Signature Select Sells Stake in SPDR Gold Trust

    GuruFocus
  79. Bristol-Myers Squibb CompanyNew Longer-Term Data for Empliciti ...

    Benzinga
  80. Amgen Expands Work With Merck, Files Biosimilar In EU

    IBD
  81. Bristol-Myers Squibb's

    IBD
  82. Bristol-Myers Plans Projects

    IBD
  83. Bristol-Myers Looks Beyond Cancer To Build Portfolio

    IBD
  84. Bristol-Myers Squibb Announces U.S. Food and Drug Administration ...

    Benzinga
  85. Goldman Sachs' Top 4 Smid-Cap Biotech Picks

    IBD
  86. Gilead Seen Staying Top Dog In HCV, But Merck Rising

    IBD
  87. BRISTOL-MYERS SQUIBB'S

    IBD
  88. Pamela Anderson And Hepatitis C: Which Drug Makers Are Working ...

    Benzinga
  89. Celgene Reports Mixed Q3 As Cancer Rivals Rise

    IBD
  90. Celgene Reports Mixed Q3 As Cancer Rivals Rise

    IBD
  91. How This Top Stock Mutual Fund Manager Seeks Growth

    IBD
  92. How This Top Stock Mutual Fund Manager Seeks Growth

    IBD
  93. Bristol-Myers Squibb

    IBD
  94. Gilead Outlook Disappoints

    IBD
  95. 4 Drugmakers Who Beat Q3 Estimates Tuesday

    IBD
  96. These Three Pharma Giants Just Crushed Earnings

    Benzinga
  97. Earnings Scheduled For October 27, 2015

    Benzinga
  98. Earnings Boom This Week: Big Pharma, E-Commerce Giant BABA And ...

    Benzinga
  99. Fed Meeting A Mid-Week Bump In Flurry Of Earnings News

    Benzinga
  100. Eli Lilly Q3 Earnings, Guidance Beat On Cost Control

    IBD
Trading Center